Karyopharm to Present at 40th Annual J.P. Morgan Healthcare Conference

NEWTON, Mass., Jan. 4, 2022 /PRNewswire/ — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that Richard Paulson, President and Chief Executive Officer of Karyopharm, will present at the 40th Annual J….

About the Author

has written 39345 stories on this site.

Copyright © 2010 Business and Corporate News.